Friday, July 10, 2020

Thermo Fisher Scientific Opens New Bioprocess Design Center in Shanghai

Facility enables customer collaboration to optimize bioprocessing solutions Thermo Fisher Scientific, the world leader in serving science, today opened its first Bioprocess Design Center in Shanghai, China. The new center is part of a strategy to...

MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

Partners with Leading Australian Healthcare Products and Biological Supplier MiMedx Group, Inc., a leading developer and marketer of regenerative and therapeutic biologics, today announced that it received regulatory approval from the Therapeutics Goods Administration (TGA)...

Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets

Company to Continue Operating Business and Serving Customers As Usual Aralez Pharmaceuticals Inc. announced today that it intends to enter into purchase agreements with two separate stalking-horse purchasers to sell its main operating businesses:  an...

Virtual Reality in Medicine and Healthcare to Generate US$285 million in 2022

Therapy and Training Services have the highest opportunity in VR medical and healthcare segment Virtual Reality (VR) has brought a range of new services into the healthcare industry.  The immersive experience provided by VR...

Heart Failure Treatment from Berlin Cures Shows Promise in Phase 1 Study

The first drug designed to eliminate autoantibodies that are a major cause of heart failure and to treat heart failure symptoms was effective and well-tolerated in a Phase 1 clinical study, according to...

Denteractive Launches 24/7 Live Online Dental Advice Service

Denteractive, an online teledentistry platform, launched a service that provides instant live professional responses to dental consumers. This service is available online 24/7, at all times of day and night. This allows people to receive advice...

AIVITA Biomedical Attains Japanese PMDA Milestone for ROOT OF CANCER Technology

Manufacturing, quality and safety data deemed acceptable by Japanese regulatory agency in AIVITA's effort to commercialize ROOT OF CANCER technology AIVITA Biomedical announced today the successful completion of the manufacturing quality consultation and clinical safety...

Kane Biotech Announces Closing of Second and Final Tranche of Private Placement

Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) is pleased to announce that it has closed the second tranche (the “Second Tranche”) of its non-brokered private placement offering (the “Offering”) previously announced on December...

Mylan Launches First AP-rated Generic Avelox® Injection

Mylan N.V. today announced the U.S. launch of Moxifloxacin Hydrochloride in 0.8% Sodium Chloride Injection, 400 mg/250 mL (1.6 mg/mL) in 250 mL single-dose flexible bags, the first AP-rated generic version of Bayer's...

RWS Expands Global Offering with RWS Life Sciences

The acquisition of LUZ, Inc. and Corporate Translations, Inc. strengthens RWS' market leadership and continued growth of life science language services On October 1, 2017 RWS, the world's leading provider of translation, intellectual property, life sciences...

Connect with us

4,406FansLike
1,007FollowersFollow
3,498FollowersFollow

Popular Posts